UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

Baker Charles D.

Conway Patrick Hugh

HEMSLEY STEPHEN J

REX JOHN F

Gil Kristen

Greg Abel, who took over as CEO of Berkshire Hathaway on December 31, executed a major portfolio overhaul in Q1 2026. He completely exited 16 positions including Amazon, Domino's Pizza, Visa, Mastercard, and UnitedHealth Group, while more than tripling Berkshire's stake in Alphabet to approximately $23 billion. The moves signal a shift toward tech investments and fundamental bargains, marking a departure from Warren Buffett's traditional investment approach.

Warren Buffett's Successor, Greg Abel, Dumped Amazon and Domino's, and More Than Tripled Berkshire's Stake in a Virtual Monopoly in a Massive Portfolio Overhaul

The global Healthcare Revenue Cycle Management (RCM) market is projected to grow from USD 171.58 billion in 2025 to USD 521.0 billion by 2035, at a CAGR of 11.72%. Growth is driven by increasing billing complexity, expanding patient volumes, AI-driven automation adoption, and the shift toward value-based care models. The U.S. market alone is expected to reach USD 234.45 billion by 2035, while Europe's market is projected at USD 133.84 billion.

Healthcare Revenue Cycle Management Market to Surpass USD 521 Billion by 2035, Driven by AI-Powered Billing Automation – SNS Insider

Doximity stock fell 24% after reporting mixed Q4 2026 earnings with only 5% sales growth and disappointing 2027 guidance of 3-5% revenue growth. The company is increasing AI spending amid a soft healthcare advertising market, pressuring profitability. Despite industry headwinds, Doximity maintains its market leadership with 85% of U.S. physicians on its platform and trades at a cheap 12x forward earnings valuation.

Why Doximity Stock Plunged Today

Schwab U.S. Dividend Equity ETF (SCHD) and iShares Core High Dividend ETF (HDV) are compared as dividend investment options. SCHD offers lower expenses (0.06%), higher yield (3.30%), and larger scale ($90.5B AUM) with a multifactor quality approach, while HDV concentrates more heavily in energy and consumer staples with a 0.08% expense ratio. SCHD delivered stronger 1-year returns (25% vs 22%) but HDV showed better 5-year total returns ($1,659 vs $1,510 on $1,000 invested). The choice depends on whether investors prioritize dividend growth and diversification (SCHD) or energy sector concentration (HDV).

SCHD Has the Scale. HDV Has the Energy Tilt. Which Dividend ETF Fits Your Portfolio?

UnitedHealth Group shows signs of turnaround with Q1 2026 results beating expectations, including 2% revenue growth and improved operating margins. The company cut Medicare Advantage membership by 1.3 million to address margin pressures from payment-cost disconnects. Analysts recommend the stock as a buy for long-term investors or a hold for those seeking dividend income, citing attractive valuation despite ongoing regulatory challenges.

Is UnitedHealth Group a Buy, Sell, or Hold in 2026?

Chief Market Strategist @FuturumEquities | Regular on @Reuters, @YahooFinance, @Bloomberg, @FoxBusiness, @SchwabNetwork & @Forbes | NIA

Shay Boloor

Institutional & Insider Insights | Investing

Hedge Vision

Official X account for The Kobeissi Letter, an industry leading commentary on the global capital markets. Email us: support@thekobeissiletter.com

The Kobeissi Letter

I teach traders how to spot strength early and trade it with conviction | Head of TA @ Stock Talk Insiders | TEL Newsletter https://t.co/dgkZrWtRFE

UnitedHealth Group Incorporated (UNH) Stock Price, Analysis & Trade Signals